Independent Medical Education
Proposal submissions for 2027 are not yet open. Please check back for updates regarding the opening of the 2027 application cycle or contact us at grants@esperion.com.
Esperion Therapeutics, Inc. seeks to advance scientific knowledge and enhance patient care by supporting independent medical education (IME) for healthcare professionals (HCPs) and researchers. Esperion considers unsolicited multi-supported educational grant requests from appropriate external organizations, and all requests must demonstrate the potential to improve the quality and outcomes of care for patients.
For more information, please click here.
Click here to submit a Medical Education Grant Request
Click here to determine the Status of An Existing Medical Education Grant Application
Click here for non-U.S. Grant Inquiries
Investigator–Initiated Studies
Proposal submissions for 2027 are open.
Esperion believes in the need to support ethical independent research conducted by qualified third-party investigators. Such research must set out to address meaningful scientific and/or clinical hypotheses supported by valid study designs, in which the privacy rights, safety, and welfare of patients is the top priority.
For more information on the application process, please click here.
Click here to submit an Investigator-Initiated Study Request
Click here to determine the Status of An Existing Investigator-Initiated Study Application
Click here for non-U.S. Grant Inquiries
ASCVD Areas of Interest
• Inflammation in ASCVD
• Non-statin LDL-C-lowering therapies
• Blood cholesterol guideline education and implementation
• Early combination lipid-lowering therapies
• Triple combination lipid lowering therapies (bempedoic acid, ezetimibe, statin)
• Familial hypercholesterolemia (FH)
• Primary and Secondary Prevention of ASCVD
Heart Failure Areas of Interest
- Novel loop diuretic delivery in HF in varied care settings *IME only, not available for IIS
- PK/PD in Heart Failure *IIS only, not available for IME
- Congestion Management *IIS only, not available for IME
- Worsening HF in outpatient setting
- Patients with HF to facilitate discharge from hospital
- Patients with HF recently discharged from hospital
- Patients from rural areas or long distance from clinic
- Patient satisfaction with intra-nasal diuretic administration
Contact Us
Esperion Grants Office
Email: grants@esperion.com
IIS Proposal submissions for 2027 are open.
IME Proposal submissions for 2027 are not yet open. Please check back for updates regarding the opening of the 2027 IME application cycle or contact us at grants@esperion.com.